iPill

Dr. Hsu, has practiced anesthesia and pain management for 28 years. Combining his knowledge of anesthesia, software and hardware, his latest innovation is using remote monitoring technology to ensure opioid prescription adherence to reduce opioid abuse and diversion. His company, iPill dispenser has 3 granted patents to fight the opioid epidemic and is FDA registered. Another company, he founded, Quivivepharma is concerned with drug development. It is combining oral opioids with an oral respiratory stimulant to counteract opioid induced respiratory respiratory depression. It is fast-tracked by the FDA and has 2 granted patents. He is devoted to making a social impact with projects that can save lives, improve healthcare, and reduce medical expenses.

Ms. Hsieh, a clinical toxicologist and Co-Founder of the iPill. She handles daily activities of the iPill. She has experience as director of marketing at Quivivepharma and was responsible for brand awareness and business development. Ms. Hsieh, leads her own private investment company.

Dr. Weinstein handles all aspects of Intellectual property, transaction, and corporate law. Dr. Weinstein currently is a Director of the company and advises the company on legal matters. His primary role is as CEO of Entralta currently and he commits 10 hours per week to iPill. Before his involvement with Quivive Pharma, Dr. Weinstein worked for many years as Senior Patent Counsel at Baxter Healthcare Corporation where he was responsible for managing legal and intellectual property matters for Baxter’s major hemophilia products like Advate® and major research and development programs in hemophilia, two of which were approved by the FDA, including Adenovate®. This work entailed working with multidisciplinary teams in the United States, Europe and Asia. Prior to Baxter, Dr. Weinstein worked in the San Diego Offices of the law firms of Brobeck, Phleger & Harrison and Fish & Richardson where his practice focused on the management and prosecution of patent portfolios for biotech and high-tech companies and patent and general civil litigation. During law school, he worked full-time as a patent agent in the Boston Office of Goodwin Procter. Dr. Weinstein also worked as an Examiner at the United States Patent and Trademark Office followed by a stint as a Senior Scientist at a biotech company where he was responsible for the Animal Health Group developing vaccines and other therapeutics for the treatment of infectious disease in large animals. Dr. Weinstein received his Ph.D. in Biology with an emphasis in Immunology from the University of Pennsylvania. Following receipt of his Ph.D., Dr. Weinstein worked as a Research Fellow, first at the National Institutes of Health in Bethesda, Maryland and then at the United States Army Medical Research Institute of Infectious Disease in Frederick, Maryland where he investigated the molecular development of antibody diversity and developed vaccines. He received his Juris Doctorate degree at Boston College Law School. Dr. Weinstein is a registered patent attorney and is licensed to practice law in California and is admitted to the U.S. District Court for the Central and Southern Districts of California.